HIGHLIGHTS
SUMMARY
As described by Riu et_al, the volume of hematoma detected at CT was the most significant factor for choosing PTAE, and a hematoma volume >1022 cc was considered a predictive factor of short-term outcome. On DSA, active bleeding was detected in 83% (20/24) of patients (80% in COVID19 group and 86% in non-COVID-19 group, p=1), much higher than the findings of Klausenitz et_al and Tani et_al, who detected active bleeding in DSA in 73.3% and 78.9% of patients, respectively. The average number of arteries embolized was 2 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.